1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester has been researched along with dihydropyridines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Born, L; Goldmann, S; Kazda, S; Pittel, B; Schramm, M | 1 |
| Fossheim, R; Mostad, A; Rømming, C; Shefter, E; Svarteng, K; Triggle, DJ | 1 |
2 other study(ies) available for 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester and dihydropyridines
| Article | Year |
|---|---|
Synthesis, pharmacological effects, and conformation of 4,4-disubstituted 1,4-dihydropyridines.
Topics: Animals; Antihypertensive Agents; Chemical Phenomena; Chemistry; Dihydropyridines; Dogs; Models, Molecular; Molecular Conformation; Muscle, Smooth, Vascular; Nifedipine; Rabbits | 1990 |
Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine.
Topics: Calcium Channel Blockers; Chemical Phenomena; Chemistry; Dihydropyridines; Models, Molecular; Molecular Conformation; Nifedipine; Phosphorylcholine; Pyridines; Structure-Activity Relationship; X-Ray Diffraction | 1982 |